Drug Type Small molecule drug |
Synonyms Inhibace Plus, Inibace Plus |
Target |
Action inhibitors |
Mechanism ACE inhibitors(Angiotensin-converting enzyme inhibitors), NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Italy (01 Jan 1997), |
Regulation- |
Molecular FormulaC22H33N3O6 |
InChIKeyJQRZBPFGBRIWSN-YOTVLOEGSA-N |
CAS Registry92077-78-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | Italy | 01 Jan 1997 |